162 related articles for article (PubMed ID: 2479772)
21. Construction of a chimaeric type 1/type 2 poliovirus by genetic recombination.
Martin A; Wychowski C; Benichou D; Crainic R; Girard M
Ann Inst Pasteur Virol; 1988; 139(1):79-88. PubMed ID: 2849960
[TBL] [Abstract][Full Text] [Related]
22. Antigen chimaeras of poliovirus as potential new vaccines.
Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW
Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279
[TBL] [Abstract][Full Text] [Related]
23. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
Thibodeau L; Lacroix M; Lecomte J; Fauvel M
Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
[TBL] [Abstract][Full Text] [Related]
24. N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152.
Wiegers K; Uhlig H; Dernick R
Virology; 1989 Jun; 170(2):583-6. PubMed ID: 2471354
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic characterization of antigenic hybrids of poliovirus.
Murdin AD; Kameda A; Murray MG; Wimmer E
Microb Pathog; 1991 Jan; 10(1):39-45. PubMed ID: 1649944
[TBL] [Abstract][Full Text] [Related]
26. Construction and characterization of hybrid hepatitis B antigen particles carrying a poliovirus immunogen.
Delpeyroux F; Crainic R; Blondel B; Horaud F; Van der Werf S; Girard M; Lagarde D; Mazert MC; Streeck RE
Biochimie; 1988 Aug; 70(8):1065-73. PubMed ID: 2465786
[TBL] [Abstract][Full Text] [Related]
27. Location and primary structure of a major antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW
Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919
[TBL] [Abstract][Full Text] [Related]
28. Mapping of type 1 poliovirus neutralization epitopes.
Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
[TBL] [Abstract][Full Text] [Related]
29. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.
Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P
J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244
[TBL] [Abstract][Full Text] [Related]
30. Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria.
van der Werf S; Charbit A; Leclerc C; Mimic V; Ronco J; Girard M; Hofnung M
Vaccine; 1990 Jun; 8(3):269-77. PubMed ID: 1694613
[TBL] [Abstract][Full Text] [Related]
31. Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1.
Minor PD; Ferguson M; Katrak K; Wood D; John A; Howlett J; Dunn G; Burke K; Almond JW
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2543-51. PubMed ID: 1701474
[TBL] [Abstract][Full Text] [Related]
32. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.
Evans DM; Minor PD; Schild GS; Almond JW
Nature; 1983 Aug 4-10; 304(5925):459-62. PubMed ID: 6192344
[TBL] [Abstract][Full Text] [Related]
33. Improved distribution of antigenic site specificity of poliovirus-neutralizing antibodies induced by a protease-cleaved immunogen in mice.
Roivainen M; Montagnon B; Chalumeau H; Murray M; Wimmer E; Hovi T
J Virol; 1990 Feb; 64(2):559-62. PubMed ID: 1688625
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
Couderc T; Hogle J; Le Blay H; Horaud F; Blondel B
J Virol; 1993 Jul; 67(7):3808-17. PubMed ID: 8389907
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a complex structure of neutralization antigenic site I of poliovirus type 1 Mahoney.
Wiegers K; Uhlig H; Dernick R
J Virol; 1988 May; 62(5):1845-8. PubMed ID: 2451760
[TBL] [Abstract][Full Text] [Related]
36. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
37. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC
J Virol; 2018 May; 92(9):. PubMed ID: 29444940
[TBL] [Abstract][Full Text] [Related]
38. [The construction of poliovirus chimera and the analysis of its antigenic structure].
Li Q; Jiang L; Zan Y; Zhao H; Guo R
Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):86-91. PubMed ID: 12549366
[TBL] [Abstract][Full Text] [Related]
39. Natural variation of poliovirus neutralization epitopes.
Crainic R; Couillin P; Blondel B; Cabau N; Boué A; Horodniceanu F
Infect Immun; 1983 Sep; 41(3):1217-25. PubMed ID: 6193066
[TBL] [Abstract][Full Text] [Related]
40. Intragenomic complementation of a 3AB mutant in dicistronic polioviruses.
Cao X; Wimmer E
Virology; 1995 Jun; 209(2):315-26. PubMed ID: 7778266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
